SYS | | r013911 |
LBL | | ^^^^^naa^^22^^^^^^^^450^ |
005 | | 20130617125721.7 |
100 | | $a 20020118a2001 m y0sloc0103 ba |
101 | 0- | $a slo |
102 | | $a CZ |
200 | 1- | $a Liečba statínmi, hladiny lipidov, C-reaktívny proteín a prežívanie pacientov s angiograficky verifikovanou ťažkou ischemickou chorobou srdca $d Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary disease $f B.D. Horne ... [et al.] |
305 | | $a J Am Coll Cardiol 2000:36:1774-80 |
320 | | $a Bibliogr. odkazy |
463 | -1 | $1 001 sllk_un_cat*sg000179_2001_001_002 $1 200 1 $a Journal of the American College of Cardiology $e JACC-SK (slovenské vydanie) $v Roč. 1, č. 2 (2001), s. 145 |
510 | 1- | $a Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary disease $z eng |
606 | 0- | $a inhibítory hydroxymetylglutaryl-CoA-reduktázy $x použitie terapeutické $2 mesh $3 sllk_un_auth*d019161 |
606 | 0- | $a C-reaktívny proteín $x analýza $x použitie diagnostické $2 mesh $3 sllk_un_auth*d002097 |
606 | 0- | $a angiografia $2 mesh $3 sllk_un_auth*d000792 |
606 | 0- | $3 sllk_un_auth*d017202 $a choroba srdca, ischemická $x diagnostika $x farmakoterapia $2 mesh |
606 | 0- | $a lipoproteíny $x analýza $x použitie diagnostické $2 mesh $3 sllk_un_auth*d008074 |
675 | | $a 616.12-009.72:616.212 $v 1. stred. $z slo |
701 | -1 | $a Horne $b B.D. $3 sllk_un_auth*p0063799 $4 560 |
702 | -1 | $a Muhlestein $b J.B. $3 sllk_un_auth*p0063800 $4 560 |
702 | -1 | $a Carlquist $b J.F. $3 sllk_un_auth*p0063801 $4 560 |
702 | -1 | $a Bair $b T.L. $3 sllk_un_auth*p0063802 $4 560 |
702 | -1 | $a Madsen $b T.E. $3 sllk_un_auth*p0063803 $4 560 |
702 | -1 | $a Hart $b N.I. $3 sllk_un_auth*p0063804 $4 560 |
702 | -1 | $a Anderson $b Jeffrey L. $3 sllk_un_auth*p0014633 $4 560 |
801 | -0 | $a SK $b BA006 $c 20020118 $g AACR2 |